TANYA SARGENT: Open Payments
NPI 1134671720 · SOMERSET, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,197 in 61 payments from 12 companies in 2025. Trend: 2023 $610 · 2024 $1,259 · 2025 $1,197
Food & beverage: $1,197
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $236 |
| AstraZeneca Pharmaceuticals LP | 5 | $236 |
| Novo Nordisk Inc | 9 | $181 |
| GlaxoSmithKline, LLC. | 8 | $136 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $81 |
| Exact Sciences Corporation | 5 | $80 |
| Amgen Inc. | 3 | $49 |
| Abbott Laboratories | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
Products named: FARXIGA, TRELEGY ELLIPTA, PREVNAR 20, Ozempic, REXULTI, JARDIANCE, The Cologuard Plus Collection Kit, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
